Stryker Orthopaedics — Segment operating income decreased by 4.3% to $649.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.0%, from $601.00M to $649.00M. Over 2 years (FY 2022 to FY 2024), Orthopaedics — Segment operating income shows an upward trend with a 8.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates improved profitability and operational performance within the orthopedic segment.
This is the primary measure of profitability for the Orthopaedics segment, calculated as segment revenue minus operating...
Standard segment operating profit metric used across all diversified medical device companies.
syk_segment_orthopaedics_segment_operating_income| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $511.00M | $455.00M | $550.50M | $550.50M | $550.50M | $550.50M | $566.25M | $566.25M | $566.25M | $566.25M | $562.00M | $634.00M | $601.00M | $794.00M | $641.00M | $678.00M | $649.00M |
| QoQ Change | — | -11.0% | +21.0% | +0.0% | +0.0% | +0.0% | +2.9% | +0.0% | +0.0% | +0.0% | -0.8% | +12.8% | -5.2% | +32.1% | -19.3% | +5.8% | -4.3% |
| YoY Change | — | — | — | +7.7% | +21.0% | — | +2.9% | +2.9% | +2.9% | +2.9% | -0.8% | +12.0% | +6.1% | +40.2% | +14.1% | +6.9% | +8.0% |
We use cookies for analytics. See our Privacy and Cookie Policy.